Loading
Latest filing published 23 Feb 2021 for Adamis Pharmaceuticals Corp.
Robert O. Hopkins discloses dealings in Adamis Pharmaceuticals Corp to SEC (Form 4). Between 6 March 2013 and 21 February 2021, the trades on record add up to 16 filings.
The open-market record consists of 11 sales worth €86k, with no purchase. Other entries cover 3 share grants and 2 option exercises.
The latest filing, published on 23 February 2021, reports an option exercise in Adamis Pharmaceuticals Corp. The median gap between a trade and its publication by SEC (Form 4) is 2 days. For comparison, the SEC allows two business days to file a Form 4. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
16 of 16 declarations